Center-Authored Papers

Filters: Author is Pidala, Joseph  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2011
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
Pidala J, Lee SJ, Quinn G, Jim H, Kim J, Anasetti C.  2011.  Variation in management of immune suppression after allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(10):1528-36. Abstract
2012
Palmer JM, Lee SJ, Chai X, Storer BE, Flowers MED, Schultz KR, Inamoto Y, Cutler C, Pidala J, Arora M et al..  2012.  Poor Agreement between Clinician Response Ratings and Calculated Response Measures in Patients with Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(11):1649-55. Abstract
Inamoto Y, Martin PJ, Chai X, Jagasia M, Palmer J, Pidala J, Cutler C, Pavletic SZ, Arora M, Jacobsohn D et al..  2012.  Clinical Benefit of Response in Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(10):1517-24. Abstract
2013
Pidala J, Chai X, Martin P, Inamoto Y, Cutler C, Palmer J, Weisdorf D, Pavletic S, Arora M, Jagasia M et al..  2013.  Hand Grip Strength and 2-Minute Walk Test in Chronic Graft-versus-Host Disease Assessment: Analysis from the Chronic GVHD Consortium.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(6):967-972. Abstract
2014
McClune BL, Woo Ahn K, Wang H-L, Antin JH, Artz AS, Cahn J-Y, Deol A, Freytes CO, Hamadani M, Holmberg LA et al..  2014.  Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(7):960-8. Abstract
Adolescent